A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Bio N Tech Se stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 7,197 shares of BNTX stock, worth $813,836. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,197
Previous 7,197 -0.0%
Holding current value
$813,836
Previous $854,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$78.36 - $124.66 $5,563 - $8,850
-71 Reduced 0.98%
7,197 $854,000
Q2 2024

Jul 29, 2024

BUY
$80.36 - $102.87 $9,241 - $11,830
115 Added 1.61%
7,268 $584,000
Q1 2024

Apr 25, 2024

BUY
$88.96 - $112.35 $10,764 - $13,594
121 Added 1.72%
7,153 $659,000
Q4 2023

Jan 30, 2024

BUY
$90.91 - $112.75 $2,363 - $2,931
26 Added 0.37%
7,032 $742,000
Q3 2023

Oct 25, 2023

SELL
$98.5 - $125.08 $22,458 - $28,518
-228 Reduced 3.15%
7,006 $761,000
Q2 2023

Aug 07, 2023

SELL
$102.58 - $129.66 $408,781 - $516,695
-3,985 Reduced 35.52%
7,234 $780,000
Q1 2023

May 08, 2023

SELL
$122.57 - $153.67 $292,206 - $366,349
-2,384 Reduced 17.53%
11,219 $1.4 Million
Q4 2022

Feb 01, 2023

SELL
$118.43 - $186.05 $232,714 - $365,588
-1,965 Reduced 12.62%
13,603 $2.04 Million
Q3 2022

Nov 09, 2022

SELL
$127.65 - $183.11 $815,172 - $1.17 Million
-6,386 Reduced 29.09%
15,568 $2.1 Million
Q2 2022

Aug 09, 2022

SELL
$123.25 - $186.24 $1.49 Million - $2.25 Million
-12,092 Reduced 35.52%
21,954 $3.27 Million
Q1 2022

Apr 21, 2022

BUY
$126.25 - $231.85 $721,392 - $1.32 Million
5,714 Added 20.17%
34,046 $5.81 Million
Q4 2021

Feb 01, 2022

BUY
$216.64 - $362.52 $3.47 Million - $5.81 Million
16,020 Added 130.12%
28,332 $7.28 Million
Q3 2021

Nov 15, 2021

SELL
$205.93 - $447.23 $379,528 - $824,244
-1,843 Reduced 13.02%
12,312 $3.36 Million
Q2 2021

Jul 30, 2021

SELL
$113.32 - $241.49 $1.13 Million - $2.41 Million
-9,963 Reduced 41.31%
14,155 $3.18 Million
Q1 2021

May 03, 2021

BUY
$85.73 - $119.5 $19,032 - $26,529
222 Added 0.93%
24,118 $2.63 Million
Q4 2020

Jan 28, 2021

BUY
$72.71 - $129.54 $109,137 - $194,439
1,501 Added 6.7%
23,896 $1.95 Million
Q3 2020

Nov 06, 2020

SELL
$57.81 - $104.17 $1,156 - $2,083
-20 Reduced 0.09%
22,395 $1.55 Million
Q2 2020

Jul 28, 2020

BUY
$38.58 - $66.74 $864,770 - $1.5 Million
22,415 New
22,415 $1.5 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.